Xeris Biopharma Raises Fiscal 2026 Revenue Guidance on Thursday
The company now expects fiscal 2026 revenue of $395 million to $405 million. Related Stocks: XERS ,
The company now expects fiscal 2026 revenue of $395 million to $405 million. Related Stocks: XERS ,